Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

25 structures for Q9C0B1

Entry ID Method Resolution Chain Position Source
3LFM X-ray 250 A A 32-505 PDB
4CXW X-ray 310 A A 32-505 PDB
4CXX X-ray 276 A A 32-505 PDB
4CXY X-ray 265 A A 32-505 PDB
4IDZ X-ray 246 A A 32-505 PDB
4IE0 X-ray 253 A A 32-505 PDB
4IE4 X-ray 250 A A 32-505 PDB
4IE5 X-ray 195 A A 32-505 PDB
4IE6 X-ray 250 A A 32-505 PDB
4IE7 X-ray 260 A A 32-505 PDB
4QHO X-ray 237 A A 32-505 PDB
4QKN X-ray 220 A A 32-503 PDB
4ZS2 X-ray 216 A A 32-505 PDB
4ZS3 X-ray 245 A A 32-505 PDB
5DAB X-ray 210 A A 32-505 PDB
5F8P X-ray 220 A A 32-502 PDB
5ZMD X-ray 330 A A/C/E/G 37-499 PDB
6AEJ X-ray 280 A PDB
6AK4 X-ray 280 A PDB
6AKW X-ray 220 A A 32-502 PDB
7CKK X-ray 235 A A 32-500 PDB
7E8Z X-ray 255 A A 32-505 PDB
7WCV X-ray 230 A A 32-505 PDB
8IT9 X-ray 214 A A 32-505 PDB
AF-Q9C0B1-F1 Predicted AlphaFoldDB

404 variants for Q9C0B1

Variant ID(s) Position Change Description Diseaes Association Provenance
rs765590518
CA8058319
RCV001121156
48 K>Q Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000625863
rs1410999299
CA396121503
88 K>R Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
rs151263395
CA8058348
RCV001856593
RCV001121157
93 P>R Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000398676
CA8058372
rs79206939
RCV000895438
134 A>T Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs147561986
CA8058375
RCV001121158
RCV002556606
143 N>S Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs201086068
CA8058376
RCV002069871
RCV001116236
144 D>N Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV000973053
CA8058385
RCV000302311
rs145884431
163 A>T Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000514150
rs61743972
CA8058392
RCV001116237
182 G>A Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001116238
RCV001862894
RCV002558147
rs150450891
CA8058403
201 V>I Lethal polymalformative syndrome, Boissel type Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001116239
rs138816516
CA8058422
241 A>T Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs2079552258
RCV002546489
RCV002546490
RCV001331558
252 P>S Lethal polymalformative syndrome, Boissel type Inborn genetic diseases [ClinVar] Yes ClinVar
dbSNP
RCV000886969
CA8058442
rs144743617
RCV001116240
256 S>N Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000266601
rs886052103
CA10648561
261 H>Q Lethal polymalformative syndrome, Boissel type Variant assessed as Somatic; impact. [ClinVar, NCI-TCGA] Yes ClinGen
ClinVar
Ensembl
NCI-TCGA
dbSNP
rs370075174
RCV001593280
RCV001117682
CA8058453
286 A>V Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000001110
rs121918214
VAR_063252
CA114727
316 R>Q Lethal polymalformative syndrome, Boissel type GDFD; has no residual normal activity, impaired ability to demethylate N(6)-methyladenosine RNAs (m6A) RNAs [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV000778469
rs1567384814
319 S>missing Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinVar
dbSNP
VAR_075468
RCV000190415
CA248803
rs781028867
319 S>F Lethal polymalformative syndrome, Boissel type GDFD; reduced enzyme activity [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
dbSNP
CA10648564
rs886052104
RCV000326322
320 T>I Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA8058474
VAR_075469
rs745616565
322 R>Q GDFD [UniProt] Yes ClinGen
UniProt
ExAC
TOPMed
dbSNP
gnomAD
rs921941344
RCV001117684
CA281970430
358 S>F Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV001117685
CA8058556
rs143788264
RCV001856545
400 M>V Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA8058559
RCV000966003
RCV001117686
VAR_032078
rs16952624
405 A>V Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV002556539
rs371704660
CA8058599
RCV001119252
428 V>M Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA8058600
RCV002556540
RCV001119253
rs141327394
RCV001856566
432 N>S Lethal polymalformative syndrome, Boissel type Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs886052107
RCV000292139
CA10647725
436 T>P Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA8058625
rs141983035
RCV000779191
462 R>* Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs763703220
RCV001119254
CA8058642
493 V>F Lethal polymalformative syndrome, Boissel type [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs201836578
CA281381707
2 K>E No ClinGen
1000Genomes
TOPMed
gnomAD
rs989161287
CA281381710
2 K>N No ClinGen
gnomAD
rs201836578
CA395927452
2 K>Q No ClinGen
1000Genomes
TOPMed
gnomAD
TCGA novel 2 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8058255
rs765157936
3 R>C No ClinGen
ExAC
gnomAD
rs1161946063
CA395927469
3 R>L No ClinGen
TOPMed
gnomAD
rs1161946063
CA395927468
3 R>P No ClinGen
TOPMed
gnomAD
CA8058256
rs752817421
4 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA395927478
rs1456216323
4 T>I No ClinGen
gnomAD
CA395927471
rs752817421
4 T>P No ClinGen
ExAC
TOPMed
gnomAD
rs1035019229
CA281381718
5 P>L No ClinGen
TOPMed
gnomAD
rs1035019229
CA281381715
5 P>R No ClinGen
TOPMed
gnomAD
rs1440570070
CA395927484
5 P>S No ClinGen
TOPMed
CA281381720
rs913398301
6 T>A No ClinGen
TOPMed
gnomAD
rs546144833
CA8058258
6 T>I No ClinGen
1000Genomes
ExAC
gnomAD
CA395927491
rs913398301
6 T>S No ClinGen
TOPMed
gnomAD
rs1329981588
CA395927514
8 E>G No ClinGen
gnomAD
rs778741837
CA8058260
8 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA281381732
rs1050722057
9 E>* No ClinGen
Ensembl
rs1050722057
CA281381729
9 E>Q No ClinGen
Ensembl
rs1282501161
CA395927527
10 R>* No ClinGen
gnomAD
rs575883122
CA8058262
10 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA395927529
rs575883122
10 R>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA395927537
rs1388384491
11 E>D No ClinGen
gnomAD
rs1016221892
CA281381752
14 A>T No ClinGen
TOPMed
gnomAD
rs1567315554
CA396120733
16 K>N No ClinGen
Ensembl
rs774232694
CA8058277
16 K>Q No ClinGen
ExAC
TOPMed
gnomAD
CA396120776
rs1211420864
23 L>V No ClinGen
TOPMed
CA8058279
rs572790599
25 D>G No ClinGen
1000Genomes
ExAC
gnomAD
CA396120797
rs1294612571
26 T>A No ClinGen
gnomAD
CA8058281
rs756522457
26 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA8058282
rs149393601
28 L>V No ClinGen
ESP
ExAC
CA396120822
rs1275818602
30 Y>H No ClinGen
gnomAD
rs373028121
CA8058284
32 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA396120837
rs1194621251
32 T>I No ClinGen
TOPMed
gnomAD
CA8058285
rs373028121
32 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA396120838
rs1292607982
33 P>T No ClinGen
gnomAD
CA396120876
rs7499606
36 D>E No ClinGen
gnomAD
CA396120872
rs1231833034
36 D>V No ClinGen
TOPMed
rs756946176
CA8058287
37 E>* No ClinGen
ExAC
gnomAD
rs780803760
CA8058289
38 F>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs769612021
CA8058290
39 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs768675500
CA396121215
42 W>* No ClinGen
ExAC
TOPMed
gnomAD
CA396121216
rs768675500
CA8058310
42 W>C No ClinGen
ExAC
TOPMed
gnomAD
CA8058311
rs778691805
43 Q>H No ClinGen
ExAC
gnomAD
CA8058314
rs773359111
44 L>R No ClinGen
ExAC
gnomAD
CA8058312
rs748048648
44 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs771274827
CA8058316
45 K>E No ClinGen
ExAC
gnomAD
CA396121245
rs1288155645
47 P>R No ClinGen
TOPMed
CA8058318
rs759800072
47 P>S No ClinGen
ExAC
gnomAD
CA281964758
COSM1609421
rs148579300
50 I>L liver [Cosmic] No ClinGen
cosmic curated
ESP
TOPMed
gnomAD
CA8058322
rs371489995
51 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM971510
CA8058321
rs371489995
51 L>I Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
COSM1378352
rs531215275
CA396121270
RCV000598325
52 R>* Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ClinVar
1000Genomes
ExAC
NCI-TCGA
dbSNP
gnomAD
rs755828209
CA8058324
52 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs779539101
CA396121302
56 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA396121312
rs1567332084
58 S>Y No ClinGen
Ensembl
CA396121330
rs753714090
60 E>D No ClinGen
ExAC
gnomAD
TCGA novel 60 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs550932456
CA8058327
62 H>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8058328
rs778727414
64 E>G No ClinGen
ExAC
CA396121361
rs1304763607
65 V>F No ClinGen
gnomAD
CA396121359
rs1304763607
65 V>I No ClinGen
gnomAD
CA281964760
rs975320571
67 E>D No ClinGen
TOPMed
CA281964761
rs555319581
68 A>G No ClinGen
gnomAD
CA396121386
rs1352866890
69 F>L No ClinGen
gnomAD
CA8058329
rs748099982
70 L>F No ClinGen
ExAC
gnomAD
rs771538354
CA281964762
71 T>A No ClinGen
Ensembl
rs772076301
CA8058330
71 T>I No ClinGen
ExAC
gnomAD
CA8058331
rs778065726
73 H>R No ClinGen
ExAC
gnomAD
rs771235427
CA8058333
74 K>N No ClinGen
ExAC
TOPMed
rs1256195889
CA396121428
75 H>Q No ClinGen
gnomAD
CA8058334
rs776743009
76 G>D No ClinGen
ExAC
gnomAD
CA8058335
rs776743009
76 G>V No ClinGen
ExAC
gnomAD
CA8058336
rs770061754
77 C>R No ClinGen
ExAC
gnomAD
CA281964763
rs143695616
80 R>Q No ClinGen
ESP
TOPMed
CA8058338
rs140101381
80 R>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8058339
rs764576608
81 D>G No ClinGen
ExAC
gnomAD
rs1417363477
CA396121468
82 L>P No ClinGen
gnomAD
CA396121470
rs773635184
83 V>F No ClinGen
ExAC
TOPMed
gnomAD
CA8058341
rs773635184
83 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs773635184
CA8058342
83 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA8058343
rs753462430
84 R>S No ClinGen
ExAC
TOPMed
gnomAD
rs1434557313
CA396121481
85 I>F No ClinGen
gnomAD
CA8058344
rs754590859
86 Q>* No ClinGen
ExAC
gnomAD
CA396121491
rs1452432547
86 Q>H No ClinGen
TOPMed
CA8058345
rs778585710
86 Q>P No ClinGen
ExAC
gnomAD
CA281964764
rs113383961
89 D>E No ClinGen
Ensembl
TCGA novel 89 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs151263395
COSM1378353
CA8058347
93 P>L Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA396121535
rs1598757445
94 V>I No ClinGen
Ensembl
rs757311078
CA8058350
96 R>C No ClinGen
ExAC
gnomAD
rs139577103
CA8058352
96 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8058351
rs139577103
96 R>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs368658799
CA8058353
97 I>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA396121565
rs1342557197
99 I>T No ClinGen
gnomAD
rs775904851
CA8058354
99 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA396121591
rs1203776934
103 G>D Variant assessed as Somatic; 4.619e-05 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA396121609
rs1479729827
106 Y>H No ClinGen
gnomAD
CA396121631
rs1253634102
108 Y>* No ClinGen
gnomAD
rs769204154
CA8058356
109 L>V No ClinGen
ExAC
gnomAD
CA396121649
rs1191932724
111 T>N No ClinGen
gnomAD
rs1392454854
CA396121653
112 R>T No ClinGen
gnomAD
rs762343983
CA8058358
115 T>M No ClinGen
ExAC
gnomAD
CA396121685
rs1160651565
117 P>R No ClinGen
TOPMed
rs759168981
CA8058361
117 P>S No ClinGen
ExAC
gnomAD
rs1473876555
CA396121701
119 P>L No ClinGen
TOPMed
CA8058362
rs774450343
120 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs867050060
CA281964769
122 G>R No ClinGen
gnomAD
CA281964768
rs867050060
122 G>W No ClinGen
gnomAD
rs1191103805
CA396121725
124 N>H No ClinGen
TOPMed
rs201792014
CA281964770
125 I>R No ClinGen
1000Genomes
CA8058364
rs374337023
126 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs914343444
CA281964771
127 H>Y No ClinGen
Ensembl
CA8058368
rs757157849
129 E>D No ClinGen
ExAC
TOPMed
gnomAD
COSM169165
rs751544648
CA8058366
129 E>K Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA8058369
rs745951679
130 A>P No ClinGen
ExAC
gnomAD
rs141423836
CA8058370
132 I>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1598757869
CA396121789
133 A>V No ClinGen
Ensembl
CA281964772
rs1051308744
139 F>L No ClinGen
Ensembl
CA8058378
rs182784714
146 L>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA396121874
rs1365423823
146 L>R No ClinGen
TOPMed
TCGA novel 147 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8058379
rs141915969
148 I>M No ClinGen
ESP
ExAC
gnomAD
CA8058380
rs775311728
150 T>A No ClinGen
ExAC
gnomAD
rs753133541
CA281964774
150 T>I No ClinGen
Ensembl
CA8058381
COSM307435
rs762625200
151 I>M kidney [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA396121906
rs1322199273
151 I>T No ClinGen
gnomAD
rs751353294
CA8058383
156 E>K No ClinGen
ExAC
gnomAD
rs1400616279
CA396121949
157 L>P No ClinGen
gnomAD
CA396121945
rs1358038241
157 L>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs371830760
CA8058384
160 K>R No ClinGen
ESP
ExAC
gnomAD
rs1292567537
CA396121982
162 K>R No ClinGen
gnomAD
rs1231516982
CA396121990
164 N>H No ClinGen
gnomAD
CA396121996
rs1332447878
164 N>K No ClinGen
TOPMed
gnomAD
rs756242925
CA396122027
169 P>S No ClinGen
ExAC
gnomAD
rs756242925
CA8058387
169 P>T No ClinGen
ExAC
gnomAD
rs754065579
CA396122033
170 L>* No ClinGen
ExAC
TOPMed
gnomAD
rs754065579
CA8058389
170 L>W No ClinGen
ExAC
TOPMed
gnomAD
rs755136162
CA8058390
173 S>F No ClinGen
ExAC
gnomAD
TCGA novel 175 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8058391
rs779309219
176 F>C No ClinGen
ExAC
gnomAD
rs1473976471
CA396122073
176 F>I No ClinGen
gnomAD
CA396122086
rs1407999347
178 R>G No ClinGen
gnomAD
rs1031617009
CA396122091
178 R>S No ClinGen
TOPMed
gnomAD
rs1248824944
CA396122089
178 R>T No ClinGen
TOPMed
rs1255477592
CA396122094
179 V>L No ClinGen
TOPMed
rs61743972
CA396122117
182 G>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs772503437
CA8058393
184 S>P No ClinGen
ExAC
gnomAD
rs1312261216
CA396122133
185 Y>C No ClinGen
TOPMed
gnomAD
CA396122141
rs1227337046
186 N>S No ClinGen
TOPMed
rs1567333363
CA396122148
187 G>E No ClinGen
Ensembl
rs577569584
CA8058395
COSM1378354
187 G>R Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 189 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 190 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA396122172
rs1282396852
190 E>D No ClinGen
gnomAD
CA8058398
rs762749778
190 E>K Variant assessed as Somatic; 9.239e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1393923768
CA396122174
191 V>M No ClinGen
TOPMed
rs1212033225
CA396122189
193 I>V No ClinGen
gnomAD
rs1257170214
CA396122199
194 K>R No ClinGen
gnomAD
rs774050560
CA8058400
197 A>T No ClinGen
ExAC
gnomAD
TCGA novel 197 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8058401
rs761651552
198 A>T No ClinGen
ExAC
gnomAD
CA281964777
rs756850408
200 N>D No ClinGen
Ensembl
rs760541418
CA8058404
204 L>M No ClinGen
ExAC
TOPMed
gnomAD
rs867677388
CA281964778
205 N>K No ClinGen
Ensembl
rs753902912
CA8058406
206 F>L No ClinGen
ExAC
gnomAD
CA396122279
rs138348216
207 M>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs138348216
CA8058407
207 M>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA396122302
rs1431584411
210 Q>* No ClinGen
gnomAD
rs752812594
CA8058409
210 Q>H No ClinGen
ExAC
TOPMed
rs779165603
CA8058408
210 Q>R No ClinGen
ExAC
gnomAD
rs1391134548
CA396122329
213 P>L No ClinGen
TOPMed
rs370009039
CA8058411
216 K>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA281964780
rs1028237381
216 K>Q No ClinGen
TOPMed
gnomAD
CA281964781
rs924124172
216 K>R No ClinGen
TOPMed
rs771548627
CA8058413
220 Y>C No ClinGen
ExAC
gnomAD
rs1484209773
CA396122382
221 F>C No ClinGen
TOPMed
CA396122381
rs1484209773
221 F>S No ClinGen
TOPMed
CA281964782
rs983657094
222 G>D No ClinGen
TOPMed
CA8058415
rs748772299
223 M>I No ClinGen
ExAC
gnomAD
CA396122393
rs1342689950
223 M>T No ClinGen
TOPMed
CA8058414
rs780601119
223 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA8058417
rs774078678
227 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs1179039850
CA396122426
228 V>L No ClinGen
gnomAD
TCGA novel 230 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs771907956
CA8058419
231 H>R No ClinGen
ExAC
gnomAD
rs1192563467
CA396122496
237 V>A No ClinGen
gnomAD
rs760665708
CA8058421
240 S>* No ClinGen
ExAC
gnomAD
rs1320667402
CA396122513
240 S>T No ClinGen
TOPMed
COSM244619
CA8058423
rs753958759
241 A>V prostate [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
TCGA novel 245 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA396122554
rs1302917355
246 S>R No ClinGen
gnomAD
rs141920596
CA8058438
251 G>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs776580855
CA8058440
252 P>R No ClinGen
ExAC
gnomAD
CA8058441
rs759400907
253 E>K No ClinGen
ExAC
gnomAD
rs369122168
CA8058443
258 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs76762929
COSM1519420
CA8058444
260 S>C lung [Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
TOPMed
gnomAD
CA281966596
rs76762929
260 S>Y No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA396119936
rs1486647785
261 H>Y No ClinGen
gnomAD
rs148528422
CA8058445
262 L>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs200452822
CA8058446
263 E>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs757723391
CA8058447
264 G>D No ClinGen
ExAC
gnomAD
CA8058448
rs756019558
265 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA396119974
rs1475617180
267 P>H No ClinGen
gnomAD
CA281966597
rs1016337772
267 P>T No ClinGen
TOPMed
gnomAD
rs1164310772
CA396119981
268 D>G No ClinGen
gnomAD
CA8058449
rs533379899
269 I>V No ClinGen
1000Genomes
ExAC
gnomAD
CA281966598
rs964254505
270 W>* No ClinGen
TOPMed
VAR_076423 271 H>P found in a patient with microcephaly, developmental delay, behavioral abnormalities, dysmorphic facial features, hypotonia and other various phenotypic abnormalities; unknown pathological significance [UniProt] No UniProt
CA281966599
rs868433402
271 H>R No ClinGen
gnomAD
CA8058450
rs756523431
272 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs920233004
CA281966600
273 G>A No ClinGen
TOPMed
TCGA novel 279 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8058451
rs778545208
281 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs1380871124
CA396120074
281 E>V No ClinGen
TOPMed
gnomAD
CA8058452
rs376957531
286 A>T No ClinGen
ESP
ExAC
TOPMed
CA396120109
rs1290922677
287 I>T No ClinGen
gnomAD
CA281966601
rs373076420
288 P>L No ClinGen
ESP
rs777382917
CA8058454
288 P>T No ClinGen
ExAC
gnomAD
CA396120125
rs1176264637
290 H>P No ClinGen
TOPMed
rs1223419681
CA396120132
291 Q>* No ClinGen
gnomAD
CA396120149
rs1239366948
293 D>V No ClinGen
gnomAD
CA396120156
rs1480708197
294 C>Y No ClinGen
TOPMed
CA396120164
rs1259762053
295 Y>C No ClinGen
gnomAD
rs1234090595
CA396120172
296 F>S No ClinGen
TOPMed
CA396120182
rs1273047834
297 M>I No ClinGen
TOPMed
CA396120178
rs1207288378
297 M>L No ClinGen
TOPMed
CA396120180
rs1212754154
297 M>T No ClinGen
gnomAD
CA396120176
rs1207288378
297 M>V No ClinGen
TOPMed
rs746623287
CA8058455
298 L>F No ClinGen
ExAC
gnomAD
CA281966603
rs777558537
299 D>H No ClinGen
gnomAD
rs1270214040
CA396120222
301 L>F No ClinGen
TOPMed
CA396120231
rs1598879991
302 N>S No ClinGen
Ensembl
rs766767212
CA8058468
304 T>A No ClinGen
ExAC
gnomAD
CA396120253
rs1350889567
306 Q>K No ClinGen
TOPMed
gnomAD
CA396120265
rs1598880061
307 H>R No ClinGen
Ensembl
CA396120263
rs1322897154
COSM1519419
307 H>Y lung Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA8058469
rs542365655
308 C>R No ClinGen
1000Genomes
ExAC
gnomAD
rs200152693
CA281969777
311 A>S No ClinGen
TOPMed
CA396120294
rs1567384728
312 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
rs1462889039
CA396120305
313 S>L No ClinGen
gnomAD
rs139814987
CA281969779
314 Q>K No ClinGen
ESP
TOPMed
gnomAD
rs777196899
CA8058471
316 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1370044478
CA396120322
317 F>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs781028867
CA8058473
319 S>Y No ClinGen
ExAC
CA281969780
COSM1378355
rs200201735
322 R>* Variant assessed as Somatic; 0.0 impact. pancreas large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
CA396120355
rs200201735
322 R>G No ClinGen
TOPMed
gnomAD
rs202007463
COSM3948593
RCV000973740
CA8058476
325 E>V ovary [Cosmic] No ClinGen
cosmic curated
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1287663418 326 C>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8058497
rs779204175
326 C>R No ClinGen
ExAC
TOPMed
gnomAD
CA8058496
rs779204175
326 C>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 329 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8058499
rs773329068
330 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs942887540
CA281970427
331 L>F No ClinGen
TOPMed
rs201510895
CA8058500
332 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8058501
rs781481485
333 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA8058503
rs760025896
336 Q>P No ClinGen
ExAC
gnomAD
rs368490949
CA8058505
337 R>C No ClinGen
ESP
ExAC
gnomAD
rs761330347
COSM191278
CA8058506
337 R>H Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA281970428
rs1020551783
338 C>F No ClinGen
Ensembl
CA8058507
rs766971002
338 C>R No ClinGen
ExAC
gnomAD
CA8058508
rs200895945
339 Q>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA396120490
rs1284248706
341 A>D No ClinGen
gnomAD
rs755738675
CA8058509
341 A>S No ClinGen
ExAC
gnomAD
rs755738675
CA396120486
341 A>T No ClinGen
ExAC
gnomAD
rs141978030
CA8058510
344 N>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM971511
CA396120533
rs1344580377
348 D>N Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
CA8058512
rs149659678
348 D>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs976522662
CA281970429
349 V>A No ClinGen
Ensembl
rs1252516403
CA396120550
350 D>E No ClinGen
TOPMed
CA8058513
rs377073096
350 D>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA396120557
rs1178634936
351 N>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA396120563
rs1457321367
352 D>A No ClinGen
TOPMed
CA8058514
rs369714221
361 P>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA396120629
rs1274518423
362 A>T No ClinGen
TOPMed
CA8058515
rs758583500
365 K>R No ClinGen
ExAC
gnomAD
TCGA novel 367 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1435299421
CA396120666
367 G>E No ClinGen
gnomAD
TCGA novel 369 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1340002370
CA396120713
373 E>V No ClinGen
gnomAD
COSM971513
rs752687224
CA8058541
375 E>K endometrium [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs777779567
CA8058543
380 R>G No ClinGen
ExAC
gnomAD
CA396120965
rs1598915445
381 Q>E No ClinGen
Ensembl
rs1254481831
CA396120976
382 F>V No ClinGen
gnomAD
rs77759235
CA281971395
383 W>L No ClinGen
Ensembl
CA8058544
rs747080793
383 W>R No ClinGen
ExAC
gnomAD
rs1598915505
CA396120990
384 F>V No ClinGen
Ensembl
CA8058545
rs757468268
385 Q>P No ClinGen
ExAC
TOPMed
gnomAD
rs781495764
CA8058546
387 N>D No ClinGen
ExAC
gnomAD
CA8058548
rs746048206
388 R>* No ClinGen
ExAC
gnomAD
rs780342015
CA8058549
388 R>P No ClinGen
ExAC
gnomAD
CA396121018
rs780342015
388 R>Q No ClinGen
ExAC
gnomAD
TCGA novel 389 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA281971396
rs1015579723
390 R>G No ClinGen
TOPMed
CA396121044
rs1465157191
392 C>R No ClinGen
gnomAD
CA8058551
rs769206684
393 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs1441842690
CA396121060
394 D>G No ClinGen
gnomAD
CA396121063
rs1567402822
395 W>R No ClinGen
Ensembl
CA8058554
rs201572715
396 W>* No ClinGen
1000Genomes
ExAC
rs1598915681
CA396121073
396 W>G No ClinGen
Ensembl
rs1598915703
CA396121081
397 C>G No ClinGen
Ensembl
CA396121087
rs1598915716
397 C>W No ClinGen
Ensembl
CA8058555
rs776456069
399 P>A No ClinGen
ExAC
gnomAD
rs372814208
CA281971397
399 P>L No ClinGen
Ensembl
CA396121099
rs372814208
399 P>R No ClinGen
Ensembl
rs776456069
CA396121097
399 P>S No ClinGen
ExAC
gnomAD
CA396121108
rs1271268742
401 A>T No ClinGen
gnomAD
CA8058557
rs765180226
402 Q>H No ClinGen
ExAC
gnomAD
CA396121187
rs1567402941
412 G>R No ClinGen
Ensembl
rs1189575941
CA396122937
418 L>F No ClinGen
TOPMed
CA8058592
rs371906409
419 H>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1222652247
CA396122952
420 E>G No ClinGen
gnomAD
CA396122956
rs748820946
421 V>F No ClinGen
ExAC
TOPMed
gnomAD
rs748820946
CA8058593
421 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA8058594
rs376527078
425 G>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA8058596
rs576410322
426 L>F No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 426 L>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 429 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1488347423
CA396123026
431 R>S No ClinGen
gnomAD
TCGA novel 431 R>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA281976283
rs145170223
433 E>G No ClinGen
ESP
TOPMed
rs1435543987
CA396123061
437 A>T No ClinGen
TOPMed
CA396123069
rs1192322094
438 I>V No ClinGen
TOPMed
gnomAD
CA8058602
rs755099738
439 L>R No ClinGen
ExAC
gnomAD
rs558995583
CA8058603
441 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1567451624
CA396123092
442 L>F No ClinGen
Ensembl
TCGA novel 444 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM558327
rs758990618
CA8058605
445 R>C lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA8058606
rs139000284
445 R>H No ClinGen
ESP
ExAC
gnomAD
rs1362586808
CA396123134
449 R>W No ClinGen
TOPMed
gnomAD
rs1399267613
CA396123149
451 E>Q No ClinGen
gnomAD
rs755686716
CA8058608
455 R>K No ClinGen
ExAC
gnomAD
rs755686716
CA396123180
455 R>M No ClinGen
ExAC
gnomAD
rs376381270
RCV000224338
CA8058624
455 R>S No ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA281991212
rs755836957
459 R>* No ClinGen
TOPMed
gnomAD
CA281991213
rs937565568
459 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
TCGA novel 461 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA396123253
rs779678337
462 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA8058626
rs779678337
462 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1277348916
CA396123274
464 L>F No ClinGen
gnomAD
CA8058629
rs761068832
465 P>H No ClinGen
ExAC
gnomAD
CA396123278
rs761068832
465 P>L No ClinGen
ExAC
gnomAD
CA8058628
rs754711298
465 P>S No ClinGen
ExAC
gnomAD
rs1599385193
CA396123285
466 A>D No ClinGen
Ensembl
rs747801335
CA8058630
467 D>N No ClinGen
ExAC
gnomAD
rs747801335
CA396123292
467 D>Y No ClinGen
ExAC
gnomAD
rs796761717
CA281991214
470 P>L No ClinGen
Ensembl
CA8058631
rs771859785
471 E>A No ClinGen
ExAC
TOPMed
gnomAD
CA396123329
rs771859785
471 E>G No ClinGen
ExAC
TOPMed
gnomAD
CA396123336
rs1291247246
472 C>Y No ClinGen
TOPMed
gnomAD
CA8058632
rs777486753
473 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA396123343
rs1254596324
473 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs529673094
CA8058634
478 K>E No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA396123391
rs1412828427
478 K>N No ClinGen
TOPMed
gnomAD
rs1450514559
CA396123393
479 D>H No ClinGen
TOPMed
CA396123402
rs1172821402
480 D>N No ClinGen
TOPMed
gnomAD
TCGA novel 481 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM971515
CA396123425
rs1401317361
482 S>L Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1458046893
CA396123433
483 M>T No ClinGen
TOPMed
CA396123439
rs1329766069
484 P>S No ClinGen
TOPMed
gnomAD
rs776819552
CA8058636
486 P>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 488 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1487911815
CA396123470
488 D>N No ClinGen
gnomAD
rs370137051
CA8058638
489 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs370137051
CA396123480
489 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs138241079
CA8058640
492 I>T No ClinGen
ESP
ExAC
gnomAD
CA8058639
rs373102373
492 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA281991215
rs763703220
COSM3387482
COSM3387481
493 V>I pancreas [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA8058646
rs750897231
496 L>H No ClinGen
ExAC
TOPMed
gnomAD
rs750897231
CA396123539
496 L>P No ClinGen
ExAC
TOPMed
gnomAD
rs1476316498
CA396123589
502 E>* No ClinGen
gnomAD
CA396123588
rs1476316498
502 E>Q No ClinGen
gnomAD
TCGA novel 503 A>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1172785826
CA396123618
505 P>L No ClinGen
TOPMed
CA8058647
rs566271902
505 P>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs953425722
CA281991216
506 P>S No ClinGen
Ensembl

2 associated diseases with Q9C0B1

[MIM: 612938]: Growth retardation, developmental delay, and facial dysmorphism (GDFD)

A severe polymalformation syndrome characterized by postnatal growth retardation, microcephaly, severe psychomotor delay, functional brain deficits and characteristic facial dysmorphism. In some patients, structural brain malformations, cardiac defects, genital anomalies, and cleft palate are observed. Early death occurs by the age of 3 years. {ECO:0000269|PubMed:19559399, ECO:0000269|PubMed:22002720, ECO:0000269|PubMed:26378117, ECO:0000269|PubMed:26697951}. Note=The disease is caused by variants affecting the gene represented in this entry.

[MIM: 601665]: Obesity (OBESITY)

A condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat. {ECO:0000269|PubMed:24646999, ECO:0000269|PubMed:26287746}. Note=Disease susceptibility is associated with variants affecting the gene represented in this entry. It is unclear whether variations associated with obesity directly affect FTO function or alter the expression of adjacent genes such as IRX3, rather than FTO itself (PubMed:24646999, PubMed:26287746). A pathogenic intronic FTO variation (rs1421085) disrupts an evolutionarily conserved motif for ARID5B binding (PubMed:26287746). Loss of ARID5B binding results in overexpression of two genes distal to FTO, IRX3 and IRX5. IRX3 and IRX5 overexpression shifts pre-adipocytes differentiation from brown to white fat cells, resulting in increased lipid storage and loss of mitochondrial thermogenesis (PubMed:26287746). {ECO:0000269|PubMed:24646999, ECO:0000269|PubMed:26287746}.

Without disease ID
  • A severe polymalformation syndrome characterized by postnatal growth retardation, microcephaly, severe psychomotor delay, functional brain deficits and characteristic facial dysmorphism. In some patients, structural brain malformations, cardiac defects, genital anomalies, and cleft palate are observed. Early death occurs by the age of 3 years. {ECO:0000269|PubMed:19559399, ECO:0000269|PubMed:22002720, ECO:0000269|PubMed:26378117, ECO:0000269|PubMed:26697951}. Note=The disease is caused by variants affecting the gene represented in this entry.
  • A condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat. {ECO:0000269|PubMed:24646999, ECO:0000269|PubMed:26287746}. Note=Disease susceptibility is associated with variants affecting the gene represented in this entry. It is unclear whether variations associated with obesity directly affect FTO function or alter the expression of adjacent genes such as IRX3, rather than FTO itself (PubMed:24646999, PubMed:26287746). A pathogenic intronic FTO variation (rs1421085) disrupts an evolutionarily conserved motif for ARID5B binding (PubMed:26287746). Loss of ARID5B binding results in overexpression of two genes distal to FTO, IRX3 and IRX5. IRX3 and IRX5 overexpression shifts pre-adipocytes differentiation from brown to white fat cells, resulting in increased lipid storage and loss of mitochondrial thermogenesis (PubMed:26287746). {ECO:0000269|PubMed:24646999, ECO:0000269|PubMed:26287746}.

2 regional properties for Q9C0B1

Type Name Position InterPro Accession
domain Alpha-ketoglutarate-dependent dioxygenase FTO, C-terminal 329 - 497 IPR024366
domain Alpha-ketoglutarate-dependent dioxygenase FTO, catalytic domain 35 - 326 IPR024367

Functions

Description
EC Number 1.14.11.53 With 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors
Subcellular Localization
  • Nucleus
  • Nucleus speckle
  • Cytoplasm
  • Localizes mainly in the nucleus, where it is able to demethylate N(6)-methyladenosine (m6A) and N(6),2'-O-dimethyladenosine cap (m6A(m)) in U6 small nuclear RNA (snRNA), N(1)-methyladenine from tRNAs and internal m6A in mRNAs (PubMed:30197295)
  • In the cytoplasm, mediates demethylation of m6A and m6A(m) in mRNAs and N(1)-methyladenine from tRNAs (PubMed:30197295)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
intracellular membrane-bounded organelle Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

7 GO annotations of molecular function

Name Definition
DNA-N1-methyladenine dioxygenase activity Catalysis of the oxidative demethylation of N1-methyladenine and N3-methylcytosine in DNA, with concomitant decarboxylation of 2-oxoglutarate and releases oxidized methyl group on N1-methyladenine and N3-methylcytosine as formaldehyde.
ferrous iron binding Binding to a ferrous iron ion, Fe(II).
mRNA N6-methyladenosine dioxygenase activity Catalysis of the oxidative demethylation of N6-methyladenosine RNA, with concomitant decarboxylation of 2-oxoglutarate and releases oxidized methyl group on N6-methyladenosine as formaldehyde.
oxidative DNA demethylase activity Catalysis of the reaction: a methylated nucleobase within DNA + 2-oxoglutarate + O(2) = a nucleobase within DNA + formaldehyde + succinate + CO(2).
oxidative RNA demethylase activity Catalysis of the removal of a methyl group from one or more nucleosides within a RNA molecule involving the oxidation (i.e. electron loss) of one or more atoms.
transferase activity Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
tRNA demethylase activity Catalysis of the removal of a methyl group from one or more positions within a tRNA molecule.

14 GO annotations of biological process

Name Definition
adipose tissue development The process whose specific outcome is the progression of adipose tissue over time, from its formation to the mature structure. Adipose tissue is specialized tissue that is used to store fat.
DNA dealkylation involved in DNA repair The repair of alkylation damage, e.g. the removal of the alkyl group at the O6-position of guanine by O6-alkylguanine-DNA alkyltransferase (AGT).
DNA demethylation The removal of a methyl group from one or more nucleotides within an DNA molecule.
mRNA destabilization Any process that decreases the stability of an mRNA molecule, making it more vulnerable to degradative processes. Messenger RNA is the intermediate molecule between DNA and protein. It includes UTR and coding sequences. It does not contain introns.
oxidative demethylation The process of removing one or more methyl groups from a molecule, involving the oxidation (i.e. electron loss) of one or more atoms in the substrate.
oxidative single-stranded DNA demethylation Removal of the methyl group from one or more nucleotides within a single-stranded DNA molecule involving the oxidation (i.e. electron loss) of one or more atoms.
oxidative single-stranded RNA demethylation Removal of the methyl group from one or more nucleotides within a single-stranded RNA molecule involving the oxidation (i.e. electron loss) of one or more atoms.
regulation of brown fat cell differentiation Any process that modulates the rate, frequency, or extent of brown fat cell differentiation. Brown fat cell differentiation is the process in which a relatively unspecialized cell acquires specialized features of a brown adipocyte, an animal connective tissue cell involved in adaptive thermogenesis. Brown adipocytes contain multiple small droplets of triglycerides and a high number of mitochondria.
regulation of lipid storage Any process that modulates the rate, frequency or extent of lipid storage. Lipid storage is the accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.
regulation of multicellular organism growth Any process that modulates the frequency, rate or extent of growth of the body of an organism so that it reaches its usual body size.
regulation of respiratory system process Any process that modulates the frequency, rate or extent of a respiratory system process, an organ system process carried out by any of the organs or tissues of the respiratory system.
regulation of white fat cell proliferation Any process that modulates the frequency, rate or extent of white fat cell proliferation.
RNA repair Any process that results in the repair of damaged RNA.
temperature homeostasis A homeostatic process in which an organism modulates its internal body temperature.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8BGW1 Fto Alpha-ketoglutarate-dependent dioxygenase FTO Mus musculus (Mouse) PR
10 20 30 40 50 60
MKRTPTAEER EREAKKLRLL EELEDTWLPY LTPKDDEFYQ QWQLKYPKLI LREASSVSEE
70 80 90 100 110 120
LHKEVQEAFL TLHKHGCLFR DLVRIQGKDL LTPVSRILIG NPGCTYKYLN TRLFTVPWPV
130 140 150 160 170 180
KGSNIKHTEA EIAAACETFL KLNDYLQIET IQALEELAAK EKANEDAVPL CMSADFPRVG
190 200 210 220 230 240
MGSSYNGQDE VDIKSRAAYN VTLLNFMDPQ KMPYLKEEPY FGMGKMAVSW HHDENLVDRS
250 260 270 280 290 300
AVAVYSYSCE GPEEESEDDS HLEGRDPDIW HVGFKISWDI ETPGLAIPLH QGDCYFMLDD
310 320 330 340 350 360
LNATHQHCVL AGSQPRFSST HRVAECSTGT LDYILQRCQL ALQNVCDDVD NDDVSLKSFE
370 380 390 400 410 420
PAVLKQGEEI HNEVEFEWLR QFWFQGNRYR KCTDWWCQPM AQLEALWKKM EGVTNAVLHE
430 440 450 460 470 480
VKREGLPVEQ RNEILTAILA SLTARQNLRR EWHARCQSRI ARTLPADQKP ECRPYWEKDD
490 500
ASMPLPFDLT DIVSELRGQL LEAKP